Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0635467B2 - Novel glycosylation method - Google Patents
[go: Go Back, main page]

JPH0635467B2 - Novel glycosylation method - Google Patents

Novel glycosylation method

Info

Publication number
JPH0635467B2
JPH0635467B2 JP2062066A JP6206690A JPH0635467B2 JP H0635467 B2 JPH0635467 B2 JP H0635467B2 JP 2062066 A JP2062066 A JP 2062066A JP 6206690 A JP6206690 A JP 6206690A JP H0635467 B2 JPH0635467 B2 JP H0635467B2
Authority
JP
Japan
Prior art keywords
benzyl
tetra
reaction
hexane
pressure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2062066A
Other languages
Japanese (ja)
Other versions
JPH03264595A (en
Inventor
誠 佐々木
康夫 蒲
昌彦 安本
裕 石上
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Institute of Advanced Industrial Science and Technology AIST
Original Assignee
Agency of Industrial Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency of Industrial Science and Technology filed Critical Agency of Industrial Science and Technology
Priority to JP2062066A priority Critical patent/JPH0635467B2/en
Publication of JPH03264595A publication Critical patent/JPH03264595A/en
Publication of JPH0635467B2 publication Critical patent/JPH0635467B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は糖アノマーの新規なグリコシル化方法に関す
る。
TECHNICAL FIELD The present invention relates to a novel glycosylation method of a sugar anomer.

[従来技術] グリコシル化法は糖アノマーの水酸基をハロゲン化した
ハロゲン化糖を銀塩あるいは水銀塩の存在下、他のアル
コール類とカップリングさせるいわゆるKoenig−
Knorr反応を利用する方法が主であった。
[Prior Art] The glycosylation method is a so-called Koenig- coupling of a halogenated sugar obtained by halogenating a hydroxyl group of a sugar anomer with another alcohol in the presence of a silver salt or a mercury salt.
The method utilizing the Knorr reaction has been the main method.

また、トリエチルアミンの存在下、メタノールのピラノ
シルブロミドによるグリコシル化法が知られているが、
より複雑なアルコール類を受容体とする反応では、収率
が非常に低い結果が得られている[C.Schuerc
h等“Carbohydr.Res.”第39巻第33
頁(1975年)]。
In addition, a glycosylation method using pyranosyl bromide of methanol in the presence of triethylamine is known.
Very low yields have been obtained in reactions involving more complex alcohols as acceptors [C. Schuerc
h et al. "Carbohydr. Res." Vol. 39, No. 33
Page (1975)].

[発明が解決しようとする問題点] Koenig−Knorr反応に代表される従来のグリ
コシル化方法を利用する場合、活性化剤として過剰の銀
あるいは水銀のような重金属塩を使うため経済的でない
という点に問題点があった。
[Problems to be Solved by the Invention] When a conventional glycosylation method represented by the Koenig-Knorr reaction is used, it is uneconomical to use an excessive heavy metal salt such as silver or mercury as an activator. There was a problem.

また、前述のScheurchらの方法では、重金属塩
を使わないという点では優れた方法であるが、メタノー
ルのような低級アルコール以外の基質には適用できな
い。
Further, the above-mentioned method of Scheurch et al. Is an excellent method in that heavy metal salts are not used, but it cannot be applied to substrates other than lower alcohols such as methanol.

[問題点を解決するための手段] 本発明者らは、アルコール類のグリコシル化法に関して
鋭意研究を行なった結果、高圧条件下において種々の水
酸基を有する受容体をグリコシル化を可能にするような
新規グリコシル化反応を見いだし、本発明を完成した。
[Means for Solving Problems] As a result of intensive studies on the glycosylation method of alcohols, the present inventors have found that receptors having various hydroxyl groups can be glycosylated under high pressure conditions. A new glycosylation reaction was found and the present invention was completed.

本発明のハロゲン化糖誘導体としては、例えばグルコピ
ラノシルブロミド、ガラクトピラノシルブロミド、マン
ノピラノシルブロミド等の通常のヘキソースのピラノシ
ルブロミド、キシロピラノシルブロミドあるいはアラビ
ノピラノシルブロミド等の通常のペントースのピラノシ
ルブロミド、これらの糖のデオキシあるいはアミノデオ
キシ誘導体などである。なお、これらのハロゲン化糖の
水酸基またはアミノ基は保護基で保護しておく。ハロゲ
ン化糖は、アルコール類に対して1.2〜1.5当量の
範囲で使用する。
The halogenated sugar derivative of the present invention includes, for example, glucopyranosyl bromide, galactopyranosyl bromide, mannopyranosyl bromide, and other common hexose pyranosyl bromides, xylopyranosyl bromides, and arabinopyranos. Examples include usual pentose pyranosyl bromides such as silbromide, and deoxy or aminodeoxy derivatives of these sugars. The hydroxyl group or amino group of these halogenated sugars is protected with a protective group. The halogenated sugar is used in the range of 1.2 to 1.5 equivalents with respect to the alcohol.

本発明の受容体化合物であるアルコール類としては、例
えばメタノール、エタノール、シクロヘキサノール、t
ert−ブチルアルコール等のアルコール類、ガラクト
ース、グリコース、マンノース等の単糖類、コレステロ
ール等のステロール類、セリン、トレオニン等のアミノ
酸類などがあげられる。
Examples of alcohols which are the acceptor compounds of the present invention include methanol, ethanol, cyclohexanol, t
Examples thereof include alcohols such as ert-butyl alcohol, monosaccharides such as galactose, glucose, mannose, sterols such as cholesterol, and amino acids such as serine and threonine.

即ち、一般式R−0Hで表されるような水酸基を有する
種々の化合物が受容体となりうる。なお、これらの受容
体化合物に他の官能基がある場合、これらは保護基によ
り保護しておく。
That is, various compounds having a hydroxyl group represented by the general formula R-0H can serve as acceptors. In addition, when these acceptor compounds have other functional groups, these are protected by a protecting group.

本発明で使用する三級アミン類としては、トリエチルア
ミン、トリブチルアミン、ジイソプロピルエチルアミ
ン、2,6−ルチジン、2,6−ジ−tert−ブチル
ピリジン、2,4,6−コリジンあるいはテトラメチル
尿素などがあげられる。三級アミン類は、アルコール類
に対して1.2〜3.0当量、好ましくは1.2〜1.
5当量の範囲で使用する。
Examples of the tertiary amines used in the present invention include triethylamine, tributylamine, diisopropylethylamine, 2,6-lutidine, 2,6-di-tert-butylpyridine, 2,4,6-collidine and tetramethylurea. can give. The tertiary amines are 1.2 to 3.0 equivalents, preferably 1.2 to 1.
Use in the range of 5 equivalents.

本発明グリコシル化は、ハロゲン化糖、アルコール類、
上記の三級アミン類及びモレキュラシーブ4Aを溶媒に
溶かし、テフロン製のカプセルに封じ込み、高圧反応容
器にセットし、カプセルに圧力をかけて反応させる。溶
媒としては、塩化メチレン、1,2−ジクロロエタン等
のハロゲン化炭化水素類、ジエチルエーテル、テトラヒ
ドロフラン、1,2−ジメトキシエタン等のエーテル
類、トルエン等の芳香族炭化水素類、アセトニトリル類
などがあげられる。
The glycosylations of the present invention include halogenated sugars, alcohols,
The above-mentioned tertiary amines and molecular sieve 4A are dissolved in a solvent, sealed in a Teflon capsule, set in a high-pressure reaction vessel, and pressure is applied to the capsule to react. Examples of the solvent include halogenated hydrocarbons such as methylene chloride and 1,2-dichloroethane, ethers such as diethyl ether, tetrahydrofuran and 1,2-dimethoxyethane, aromatic hydrocarbons such as toluene, acetonitriles and the like. To be

反応圧力については、4000〜15000気圧の範囲
で設定できるが、8000〜15000気圧の範囲が望
ましい。反応温度については、室温から100℃の範囲
で目的物に応じて設定できるが、室温から40℃が適当
である。反応時間は受容体の反応性、反応温度により左
右され一定しないが、通常は、20〜40時間程度で充
分である。
The reaction pressure can be set in the range of 4000 to 15000 atm, but is preferably in the range of 8000 to 15000 atm. The reaction temperature can be set in the range of room temperature to 100 ° C. according to the intended product, but room temperature to 40 ° C. is suitable. The reaction time is not constant depending on the reactivity of the receptor and the reaction temperature, but 20 to 40 hours is usually sufficient.

本発明において得られた化合物は、シリカゲルカラムク
ロマトグラフィー、再結晶などの通常の手段により精製
することができる。
The compound obtained in the present invention can be purified by a usual means such as silica gel column chromatography and recrystallization.

[発明の効果] 本発明の方法に従い、高圧条件下、ハロゲン化糖誘導体
とアルコール類から、対応するグリコシル化合物が得ら
れる。本発明の方法は操作が簡便であり、銀あるいは水
銀などの重金属塩を一切用いる必要がない点で従来の方
法に比較して、安全で経済的方法である。また、後述す
る実施例に示すとおり、本発明の方法に従えば、α−O
−グリコシド結合を高い選択性で得ることができる。
[Effect of the Invention] According to the method of the present invention, the corresponding glycosyl compound can be obtained from the halogenated sugar derivative and the alcohol under high pressure conditions. The method of the present invention is a safe and economical method as compared with the conventional method in that the operation is simple and it is not necessary to use any heavy metal salt such as silver or mercury. Further, as shown in Examples described later, according to the method of the present invention, α-O
-Glycoside bonds can be obtained with high selectivity.

[実施例] 次に本発明を実施例に基づき、さらに詳細に説明する。EXAMPLES Next, the present invention will be described in more detail based on examples.

実施例1 O−(2,3,4,6−テトラ−O−ベンジル−D−グ
ルコピラノシル)コレステロール(1) 2,3,4,6−テトラ−O−ベンジル−α−D−グル
コピラノシルブロミド(181.3mg,0.301mmo
l)、コレステロール(96.7mg,0.251mmo
l)、2,6−ルチジン(35μ,0.300mmol)
及びモレキュラシーブ4A(約100mg)を測りとり、
これに塩化メチレン(2m)を加えて溶かし、テフロ
ン製のカプセルに封じ込み、高圧反応容器にセットし
た。カプセルに約8000気圧の圧力をかけ、室温で2
0時間反応させた。圧力を常圧にもどし、不溶物をセラ
イトで濾過し、減圧下溶媒を留去した。得られた粗生成
物をシリカゲルカラムクロマトグラフィー(シリカ10
g、5→10%酢酸エチル−ヘキサン)に供し、αとβ
の混合物(1) (151.7mg,67%)を得た。
Example 1 O- (2,3,4,6-tetra-O-benzyl-D-glucopyranosyl) cholesterol (1) 2,3,4,6-tetra-O-benzyl-α-D-glucopyranosyl Bromide (181.3mg, 0.301mmo
l), cholesterol (96.7mg, 0.251mmo
l), 2,6-lutidine (35 μ, 0.300 mmol)
And molecular sieve 4A (about 100 mg),
Methylene chloride (2 m) was added to and dissolved therein, and the mixture was sealed in a Teflon capsule and set in a high-pressure reaction vessel. Apply a pressure of about 8000 atm to the capsules, and
The reaction was allowed for 0 hours. The pressure was returned to normal pressure, the insoluble material was filtered through Celite, and the solvent was evaporated under reduced pressure. The obtained crude product was subjected to silica gel column chromatography (silica 10
g, 5 → 10% ethyl acetate-hexane), and α and β
To obtain a mixture (1) (151.7 mg, 67%).

HPLC(8%酢酸エチル−ヘキサン、流速1m/mi
n) tr(trは液クロのリテンションタイムを示す) α:10.4min,β:7.9min α/β=93/7 さらに分取薄層クロマトグラフィーによりα体を分取
し、エタノールら再結晶した。
HPLC (8% ethyl acetate-hexane, flow rate 1 m / mi
n) tr (tr indicates the retention time of liquid chromatography) α: 10.4 min, β: 7.9 min α / β = 93/7 Further, the α-form was separated by preparative thin-layer chromatography and re-extracted from ethanol. It crystallized.

mp 145−145.5℃ (式中、Bnはベンジル基を表わす。) 実施例2 シクロハキシル 2,3,4,6−テトラ−O−ベンジ
ル−D−グルコピラノシド(2) 2,3,4,6−テトラ−O−ベンジル−α−D−グル
コピラノシルブロミド(179.2mg,0.297mmo
l)、シクロヘキサノール(24.9mg,0.246mmo
l)、2,6−ルチジン(35μ,0.300mmol)
及びモレキュラシーブ4A(約100mg)を測りとり、
これに塩化メチレン(2m)を加えて溶かし、テフロ
ン製のカプセルに封じ込み、高圧反応容器にセットし
た。カプセルに約8000気圧の圧力をかけ、室温で2
0時間反応させた。圧力を常圧に戻し、不溶物をセライ
トで濾過し、クロロホルムで希釈後、0.5M塩酸水溶
液で洗浄した。無水硫酸マグネシウムで乾燥後、減圧下
溶媒を留去し、得られた粗生成物をシリカゲルカラムク
ロマトグラフィー(シリカ15g、1:5→1:4 酢
酸エチル−ヘキサン)に供し、αとβの混合物(2) (122.7mg,79%)を得た。
mp 145-145.5 ° C (In the formula, Bn represents a benzyl group.) Example 2 Cyclohaxyl 2,3,4,6-tetra-O-benzyl-D-glucopyranoside (2) 2,3,4,6-tetra-O-benzyl- α-D-glucopyranosyl bromide (179.2 mg, 0.297 mmo
l), cyclohexanol (24.9mg, 0.246mmo
l), 2,6-lutidine (35 μ, 0.300 mmol)
And molecular sieve 4A (about 100 mg),
Methylene chloride (2 m) was added to and dissolved therein, and the mixture was sealed in a Teflon capsule and set in a high-pressure reaction vessel. Apply a pressure of about 8000 atm to the capsules, and
The reaction was allowed for 0 hours. The pressure was returned to normal pressure, the insoluble material was filtered through Celite, diluted with chloroform, and washed with a 0.5 M aqueous hydrochloric acid solution. After drying over anhydrous magnesium sulfate, the solvent was evaporated under reduced pressure, and the obtained crude product was subjected to silica gel column chromatography (silica 15 g, 1: 5 → 1: 4 ethyl acetate-hexane) to give a mixture of α and β. (2) (122.7 mg, 79%) was obtained.

HPLC(10%酢酸エチル−ヘキサン、流速1m/
min) tr α:10.6min,β:9.0min α/β=92/8 (式中、Bnはベンジル基を表わす。) 実施例3 tert−ブチル 2,3,4,6−テトラ−O−ベン
ジル−D−グルコピラノシド(3) 2,3,4,6−テトラ−O−ベンジル−α−D−グル
コピラノシルブロミド(203.1mg,0.337mmo
l)、tert−ブチルアルコール(20.6mg,0.
278mmol)、2,6−ルチジン(39μ,0.33
5mmol)及びモレキュラシーブ4A(約100mg)を塩
化メチレン(2m)に溶かし、テフロン製のカプセル
に封じ、8000気圧の圧力をかけ、室温で20時間反
応させた。実施例2と同様の後処理を行ない、得られた
粗生成物をシリカゲルカラムクロマトグラフィー(シリ
カ15g,1:5→1:4 酢酸エチル−ヘキサン)に
供し、αとβの混合物(3) (98.5mg,59%)を得た。
HPLC (10% ethyl acetate-hexane, flow rate 1 m /
min) tr α: 10.6 min, β: 9.0 min α / β = 92/8 (In the formula, Bn represents a benzyl group.) Example 3 tert-butyl 2,3,4,6-tetra-O-benzyl-D-glucopyranoside (3) 2,3,4,6-tetra-O- Benzyl-α-D-glucopyranosyl bromide (203.1 mg, 0.337 mmo
l), tert-butyl alcohol (20.6 mg, 0.
278 mmol), 2,6-lutidine (39 μ, 0.33
(5 mmol) and molecular sieve 4A (about 100 mg) were dissolved in methylene chloride (2 m), the mixture was sealed in a Teflon capsule, and a pressure of 8000 atm was applied, and the reaction was carried out at room temperature for 20 hours. The same post-treatment as in Example 2 was performed, and the obtained crude product was subjected to silica gel column chromatography (silica 15 g, 1: 5 → 1: 4 ethyl acetate-hexane) to give a mixture of α and β (3) ( 98.5 mg, 59%) was obtained.

HPLC(10%酢酸エチル−ヘキサン,流速1m/
min) tr α:10.9min,β:9.9min α/β=93/7 (式中、Bnはベンジル基を表わす。) 実施例4 メチル 2,3,4,−トリ−O−ベンジル−6−O−
(2,3,4,6−テトラ−O−ベンジル−D−グルコ
ピラノシル)−α−D−グルコピラノシド(4) 2,3,4,6−テトラ−O−ベンジル−α−D−グル
コピラノシルブロミド(232.2mg,0.385mmo
l)、メチル 2,3,4−トリ−O−ベンジル−α−
D−グルコピラノシド (117.6mg,0.253mmol)、ジイソプロピルエ
チルアミン(70μ,0.402mmol)及びモレキュ
ラシーブ4A(約100mg)を塩化メチレン(2m)
に溶かし、テフロン製のカプセルに封じ、40℃、80
00気圧で20時間反応させた。実施例2と同様の後処
理を行ない、得られた粗生成物をシリカゲルカラムクロ
マトグラフィー(シリカ10g,10→20% 酢酸エ
チル−ヘキサン)に供し、αとβの混合物(4) (171.8mg,69%)を得た。
HPLC (10% ethyl acetate-hexane, flow rate 1 m /
min) tr α: 10.9 min, β: 9.9 min α / β = 93/7 (In the formula, Bn represents a benzyl group.) Example 4 Methyl 2,3,4, -tri-O-benzyl-6-O-
(2,3,4,6-Tetra-O-benzyl-D-glucopyranosyl) -α-D-glucopyranoside (4) 2,3,4,6-tetra-O-benzyl-α-D-glucopyranosyl Bromide (232.2mg, 0.385mmo
l), methyl 2,3,4-tri-O-benzyl-α-
D-glucopyranoside (117.6 mg, 0.253 mmol), diisopropylethylamine (70 μ, 0.402 mmol) and molecular sieve 4A (about 100 mg) were added to methylene chloride (2 m).
Dissolve in, seal in a Teflon capsule, 40 ℃, 80
The reaction was carried out at 00 atm for 20 hours. The same post-treatment as in Example 2 was performed, and the resulting crude product was subjected to silica gel column chromatography (silica 10 g, 10 → 20% ethyl acetate-hexane) to give a mixture of α and β (4) (171.8 mg). , 69%).

HPLC(ヘキサン/THF=5/1,流速1m/mi
n) tr α:15.7min,β:13.9min α/β=85/15 (式中、Bnはベンジル基を表わす。) 実施例5 1,2,3,4−ジ−O−イソプロピリデン−6−O−
(2,3,4,6−テトラ−O−ベンジル−D−グルコ
ピラノシル)−α−D−カラクトピラノシド(5) 2,3,4,6−テトラ−O−ベンジル−α−D−グル
コピラノシルブロミド(185.0mg,0.307mmo
l)、1,2,3,4−ジ−O−イソプロピリデン−α
−D−ガラクトピラノース(65.7mg,0.252mm
ol)、ジイソプロピルエチルアミン(53μ,0.3
04mmol)及びモレキュラシーブ4A(約100mg)を
塩化メチレン(2m)に溶かし、テフロン製のカプセ
ルに封じ、25℃、約8000気圧で44時間反応させ
た。実施例2と同様の後処理をし、得られた粗生成物を
シリカゲルカラムクロマトグラフィー(シリカ10g、
10→20% 酢酸エチル−ヘキサン)に供し、αとβ
の混合物(5) (156.0mg,79%)を得た。
HPLC (hexane / THF = 5/1, flow rate 1 m / mi
n) tr α: 15.7 min, β: 13.9 min α / β = 85/15 (In the formula, Bn represents a benzyl group.) Example 5 1,2,3,4-di-O-isopropylidene-6-O-
(2,3,4,6-Tetra-O-benzyl-D-glucopyranosyl) -α-D-galactopyranoside (5) 2,3,4,6-tetra-O-benzyl-α-D-gluco Pyranosyl bromide (185.0 mg, 0.307 mmo
l), 1,2,3,4-di-O-isopropylidene-α
-D-galactopyranose (65.7 mg, 0.252 mm)
ol), diisopropylethylamine (53μ, 0.3
(04 mmol) and molecular sieves 4A (about 100 mg) were dissolved in methylene chloride (2 m), encapsulated in a Teflon capsule, and reacted at 25 ° C. and about 8000 atm for 44 hours. The same post-treatment as in Example 2 was carried out, and the resulting crude product was subjected to silica gel column chromatography (silica 10 g,
10 → 20% ethyl acetate-hexane) to obtain α and β
To give a mixture (5) of (156.0 mg, 79%).

HPLC(20%酢酸エチル−ヘキサン,流速1m/
min) tr α:10.2min,β:11.6min α/β=88/12 (式中、Bnはベンジル基を表わす。) 実施例6 1,2,3,4−テトラ−O−アセチル−6−O−
(2,3,4,6−テトラ−O−ベンジル−D−グルコ
ピラノシル)−β−D−グルコピラノース(6) 2,3,4,6−テトラ−O−ベンジル−α−D−グル
コピラノシルブロミド(182.5mg,0.303mmo
l)、1,2,3,4−テトラ−O−アセチル−β−D
−グルコピラノース(87.0mg,0.250mmol)、
2,6−ルチジン(35μ,0.300mmol)及びモ
レキュラシーブ4A(約100mg)を塩化メチレン(2
m)に溶かし、テフロン製のカプセルに封じ、25
℃、約8000気圧で20時間反応させた。実施例2と
同様の後処理をし、得られた粗成生物をシリカゲルカラ
ムクロマトグラフィー(シリカ20g、30→35%
酢酸エチル−ヘキサン)に供し、αとβの混合物(6)
(104.8mg,48%)を得た。
HPLC (20% ethyl acetate-hexane, flow rate 1 m /
min) tr α: 10.2 min, β: 11.6 min α / β = 88/12 (In the formula, Bn represents a benzyl group.) Example 6 1,2,3,4-tetra-O-acetyl-6-O-
(2,3,4,6-Tetra-O-benzyl-D-glucopyranosyl) -β-D-glucopyranose (6) 2,3,4,6-tetra-O-benzyl-α-D-glucopyrano Silbromide (182.5mg, 0.303mmo
l), 1,2,3,4-tetra-O-acetyl-β-D
-Glucopyranose (87.0 mg, 0.250 mmol),
2,6-lutidine (35 μ, 0.300 mmol) and molecular sieve 4A (about 100 mg) were added to methylene chloride (2
m), seal in Teflon capsules, 25
The reaction was carried out at a temperature of about 8000 atm for 20 hours. The same post-treatment as in Example 2 was carried out, and the resulting crude product was subjected to silica gel column chromatography (silica 20 g, 30 → 35%.
Ethyl acetate-hexane), and a mixture of α and β (6)
(104.8 mg, 48%) was obtained.

HPLC(3%エタノール−ヘキサン,流速1m/mi
n) tr α:10.7min,β:9.8min α/β=94/6 (式中、Bnはベンジル基、Acはアセチル基を表わ
す。) 実施例7 N−ベンジルオキシカルボニル−O−(2,3,4,6
−テトラ−O−ベンジル−α−D−グルコピラノシル)
−L−セリン メチルエステル(7) 2,3,4,6−テトラ−O−ベンジル−α−D−グル
コピラノシルブロミド(189.3mg,0.314mmo
l)、N−ベンジルオキシカルボニル−L−セリン メ
チルエステル(65.3mg,0.258mmol)、2,6
−ルチジン(36μ,0.309mmol)及びモレキュ
ラシーブ4A(約100mg)を塩化メチレン(2m)
に溶かし、テフロン製のカプセルに封じ込み、25℃、
約8000気圧で20時間反応させた。実施例2と同様
の後処理を行ない、得られた粗成生物をシリカゲルカラ
ムクロマトグラフィー(シリカ15g、5→10% エ
ーテル−ベンゼン)に供し、αとβの混合物(7)(1
19.2mg,60%)を得た。
HPLC (3% ethanol-hexane, flow rate 1 m / mi
n) tr α: 10.7 min, β: 9.8 min α / β = 94/6 (In the formula, Bn represents a benzyl group and Ac represents an acetyl group.) Example 7 N-benzyloxycarbonyl-O- (2,3,4,6)
-Tetra-O-benzyl-α-D-glucopyranosyl)
-L-serine methyl ester (7) 2,3,4,6-tetra-O-benzyl-α-D-glucopyranosyl bromide (189.3 mg, 0.314 mmo
l), N-benzyloxycarbonyl-L-serine methyl ester (65.3 mg, 0.258 mmol), 2,6
-Lutidine (36μ, 0.309mmol) and molecular sieve 4A (about 100mg) in methylene chloride (2m).
Dissolve in, seal in a Teflon capsule, 25 ℃,
The reaction was carried out at about 8000 atm for 20 hours. The same post-treatment as in Example 2 was performed, and the obtained crude product was subjected to silica gel column chromatography (silica 15 g, 5 → 10% ether-benzene) to give a mixture of α and β (7) (1).
19.2 mg, 60%) was obtained.

HPLC(アセトニトリル/水=5/1,流速1m/
min) tr α:10.1min,β:11.5min α/β=95/5 (式中、Bnはベンジル基を表わす。)
HPLC (acetonitrile / water = 5/1, flow rate 1 m /
min) tr α: 10.1 min, β: 11.5 min α / β = 95/5 (In the formula, Bn represents a benzyl group.)

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】ハロゲン化糖誘導体を三級アミン類の存在
下、アルコール類と高圧条件下(4000気圧以上)反
応させることを特徴とするグリコシル化法。
1. A glycosylation method, which comprises reacting a halogenated sugar derivative with an alcohol in the presence of a tertiary amine under high pressure conditions (at least 4000 atm).
JP2062066A 1990-03-13 1990-03-13 Novel glycosylation method Expired - Lifetime JPH0635467B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2062066A JPH0635467B2 (en) 1990-03-13 1990-03-13 Novel glycosylation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2062066A JPH0635467B2 (en) 1990-03-13 1990-03-13 Novel glycosylation method

Publications (2)

Publication Number Publication Date
JPH03264595A JPH03264595A (en) 1991-11-25
JPH0635467B2 true JPH0635467B2 (en) 1994-05-11

Family

ID=13189362

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2062066A Expired - Lifetime JPH0635467B2 (en) 1990-03-13 1990-03-13 Novel glycosylation method

Country Status (1)

Country Link
JP (1) JPH0635467B2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0647233A1 (en) * 1992-06-26 1995-04-12 Pfizer Inc. Steroidal beta-o-cellobioside heptaalkanoate process
CN103864860B (en) * 2014-03-17 2016-08-31 柯中炉 A kind of trehalose derivative and its preparation method and application
JP6467762B2 (en) * 2017-02-10 2019-02-13 香港友池有限公司 Method for producing glycosylated stilbenoid compound
WO2018147306A1 (en) * 2017-02-10 2018-08-16 マイスターバイオ株式会社 Method for producing glycosylated stilbenoid compound

Also Published As

Publication number Publication date
JPH03264595A (en) 1991-11-25

Similar Documents

Publication Publication Date Title
JP3231765B2 (en) Method for producing demethyl epipodophyllotoxin
JP2001527568A (en) Novel glycosylated derivative of gingolide, its use as medicament and pharmaceutical composition containing it
JPH0635467B2 (en) Novel glycosylation method
JP3816570B2 (en) Acylating agent
JP2540400B2 (en) Method for producing L-talopyranoside derivative
US8524873B2 (en) Sugar donor
Dumont-Hornebeck et al. Synthesis of di-and trisaccharides incorporating a crown ether macrocycle
JPH0742304B2 (en) Novel anthracycline derivative and method for producing the same
US5344924A (en) Solvent-free synthesis of ethereally substituted blocked monosaccharides and the selective hydrolysis thereof
AU641644B2 (en) A process for the preparation of etoposides
AU601552B2 (en) N-acetyl-3-fluoro-neuraminic acid derivatives and preparation thereof
US6075132A (en) Ursodeoxycholic acid derivatives and methods for producing them
Wessel et al. Selectively Deoxygenated Derivatives of β-Maltosyl-(1→ 4)-Trehalose as Biological Probes
TAKIURA et al. Studies of Oligosaccharides. X. Synthesis of Isomaltose and Isomaltotriose by Benzyl Blocking Method
Rosenthal et al. 9-[3-acetamido-3-C-(carboxymethyl)-3-deoxy-32, 2-lactone-α (andβ)-D-xylofuranosyl] adenine-analogs of the nucleoside moiety of the polyoxins
CN111269279B (en) A kind of method for preparing halogenated sugar under mild conditions
JPH11279192A (en) Production of new chromanol glycoside
JP3265425B2 (en) Phosphorylated trisaccharide serine, sulfated / phosphorylated trisaccharide serine, and methods for their synthesis
HU207337B (en) Process for producing tetrasaccharides
JPH09241288A (en) Stereoselective method for producing glycosyl compound
HUT62305A (en) Process for producing sugar epitops
JPH02295996A (en) Preparation of glucosaminyl-epi-podophyllotoxin derivative
EP0582153B1 (en) Method of preparing 4-deoxy-D-mannose
JP3542143B2 (en) Method for producing oligosaccharide
JP2694282B2 (en) Glycosylation method

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term